Literature DB >> 15356308

Thiazolidinediones.

Hannele Yki-Järvinen1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15356308     DOI: 10.1056/NEJMra041001

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  546 in total

1.  Rosiglitazone improves lipoatrophy in patients receiving thymidine-sparing regimens.

Authors:  Marisa Tungsiripat; Dalia El Bejjani; Nesrine Rizk; Mary Ann O'riordan; Allison C Ross; Corrilynn Hileman; Norma Storer; Danielle Harrill; Grace A McComsey
Journal:  AIDS       Date:  2010-06-01       Impact factor: 4.177

2.  Peroxisome proliferator-activated receptor γ inhibits pulmonary hypertension targeting store-operated calcium entry.

Authors:  Yingfeng Wang; Wenju Lu; Kai Yang; Yan Wang; Jie Zhang; Jing Jia; Xin Yun; Lichun Tian; Yuqin Chen; Qian Jiang; Bo Zhang; Xiuqing Chen; Jian Wang
Journal:  J Mol Med (Berl)       Date:  2014-11-14       Impact factor: 4.599

3.  Effects of intensive insulin therapy alone and in combination with pioglitazone on body weight, composition, distribution and liver fat content in patients with type 2 diabetes.

Authors:  P K Shah; S Mudaliar; A R Chang; V Aroda; M Andre; P Burke; R R Henry
Journal:  Diabetes Obes Metab       Date:  2011-06       Impact factor: 6.577

4.  Crystal structure of human mitoNEET reveals distinct groups of iron sulfur proteins.

Authors:  Jinzhong Lin; Tao Zhou; Keqiong Ye; Jinfeng Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-31       Impact factor: 11.205

Review 5.  Updates on the management of diabetes in dialysis patients.

Authors:  Connie M Rhee; Angela M Leung; Csaba P Kovesdy; Katherine E Lynch; Gregory A Brent; Kamyar Kalantar-Zadeh
Journal:  Semin Dial       Date:  2014-03       Impact factor: 3.455

6.  Relationship between thiazolidinedione use and cardiovascular outcomes and all-cause mortality among patients with diabetes: a time-updated propensity analysis.

Authors:  Zeina A Habib; Leonidas Tzogias; Suzanne L Havstad; Karen Wells; George Divine; David E Lanfear; Jeffrey Tang; Richard Krajenta; Manel Pladevall; L Keoki Williams
Journal:  Pharmacoepidemiol Drug Saf       Date:  2009-06       Impact factor: 2.890

7.  Peroxisome proliferator-activated receptor gamma activation restores islet function in diabetic mice through reduction of endoplasmic reticulum stress and maintenance of euchromatin structure.

Authors:  Carmella Evans-Molina; Reiesha D Robbins; Tatsuyoshi Kono; Sarah A Tersey; George L Vestermark; Craig S Nunemaker; James C Garmey; Tye G Deering; Susanna R Keller; Bernhard Maier; Raghavendra G Mirmira
Journal:  Mol Cell Biol       Date:  2009-02-23       Impact factor: 4.272

Review 8.  Thyroid Dysfunction and Diabetes Mellitus: Two Closely Associated Disorders.

Authors:  Bernadette Biondi; George J Kahaly; R Paul Robertson
Journal:  Endocr Rev       Date:  2019-06-01       Impact factor: 19.871

Review 9.  Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing Agents.

Authors:  Antonino Di Pino; Ralph A DeFronzo
Journal:  Endocr Rev       Date:  2019-12-01       Impact factor: 19.871

10.  Rosiglitazone stimulates adipogenesis and decreases osteoblastogenesis in human mesenchymal stem cells.

Authors:  S Benvenuti; I Cellai; P Luciani; C Deledda; S Baglioni; C Giuliani; R Saccardi; B Mazzanti; S Dal Pozzo; E Mannucci; A Peri; M Serio
Journal:  J Endocrinol Invest       Date:  2007-10       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.